The analysis of Global Total Internal R&D Personnel in the Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations highlights key countries and their standing as of 2024. China leads with a significant number of R&D personnel, followed by Japan and Germany. South Korea shows promising growth with a 6.14% year-on-year increase, while the UK demonstrates a noteworthy 12.62% rise. Conversely, nations like Israel and Norway saw declines in their R&D personnel, reflecting varying national priorities and investments.
Looking ahead, the pharmaceutical R&D landscape will likely prioritize automation and AI to enhance drug discovery and development efficiencies. Countries that invest in biotechnological advancements and foster international collaborations stand to benefit greatly. Monitoring global policies and talent migration trends will also be crucial for understanding the future trajectory of R&D personnel distribution.
Top countries in Total Internal R&D Personnel in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by Country
| # | 10 Countries | Units (Full-Time Equivalent) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 156,440 | 2023 | +4.91% | +4.44% | View data |
| 2 | 2 Japan | 26,180 | 2023 | -0.89% | -0.79% | View data |
| 3 | 3 Germany | 22,410 | 2023 | +0.95% | +1.14% | View data |
| 4 | 4 South Korea | 11,590 | 2023 | +5% | +6.14% | View data |
| 5 | 5 Italy | 5,540 | 2023 | +1.84% | +2.79% | View data |
| 6 | 6 Spain | 5,430 | 2023 | +0.95% | +0.99% | View data |
| 7 | 7 United Kingdom | 4,210 | 2023 | +2.41% | +12.62% | View data |
| 8 | 8 Canada | 3,750 | 2023 | +0.13% | -0.4% | View data |
| 9 | 9 Taiwan | 3,060 | 2023 | +2.68% | +1.02% | View data |
| 10 | 10 Hungary | 2,500 | 2023 | +0.36% | -0.12% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
